← Back to headlines
Novo Nordisk to Invest €430 Million in Athlone Plant for Wegovy Production
Novo Nordisk, the company behind the injectable weight-loss drug Wegovy, plans to invest €430 million in its Athlone plant to enhance the production of Wegovy in pill form.
2 Mar, 14:34 — 2 Mar, 14:34
Sources
Showing 1 of 1 sources
